Author Page for Nicola Pavese

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

PADOVA: A Phase IIb, Multicentre, Randomised, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Individuals with Early-Stage Parkinson Disease on Stable Symptomatic Monotherapy

Number of pages: 39 Posted: 06 Feb 2026

F Hoffmann-La Roche Ltd, F Hoffmann-La Roche Ltd, F Hoffmann-La Roche Ltd, F Hoffmann-La Roche Ltd, F Hoffmann-La Roche Ltd, Northwestern University (Philippines) - Department of Neurology, Institute for Neurodegenerative Disorders, Newcastle University, Medical University of Innsbruck, University San Raffaele Roma, McGill University - Montreal General Hospital, Roche, F Hoffmann-La Roche Ltd, Roche, Roche, Roche, Roche, F Hoffmann-La Roche Ltd, Roche - Roche Pharma Research and Early Development, F Hoffmann-La Roche Ltd, F Hoffmann-La Roche Ltd and affiliation not provided to SSRN

Downloads 122 (592,433)

Abstract:

Decoding Prodromal Parkinson's Disease: Clinical Differences between Isolated Hyposmia and Rem Sleep Behavior Disorder

Number of pages: 27 Posted: 10 Jul 2025

Luke Vikram Banerjee, Jacopo Pasquini, Robin Henderson, Nicola Pavese and Kirstie N. Anderson

Newcastle University, Newcastle University, Newcastle University, Newcastle University and Newcastle University

Downloads 36 (1,236,159)

Nicola Pavese

Newcastle University

2

158

0

Scholarly Papers (2)

PADOVA: A Phase IIb, Multicentre, Randomised, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Individuals with Early-Stage Parkinson Disease on Stable Symptomatic Monotherapy

Abstract:

Decoding Prodromal Parkinson's Disease: Clinical Differences between Isolated Hyposmia and Rem Sleep Behavior Disorder

Abstract: